Here's Shares Agios Pharmaceuticals: 2026 Outlook and Rally
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Selecting a credit card requires careful consideration. Discover the key factors to keep in mind to make the best choice for your finances.
18,103 articlesBiotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Investors are weighing NuScale Power as the small modular reactor (SMR) pioneer. This guide breaks down factors that ...
Broadcom is shifting from a broad tech portfolio to a focused AI chip powerhouse. If the company can turn custom AI c...
The AI race keeps evolving, and Alphabet sits at the center. A rumored Anthropic cloud deal hints at how hyperscale i...
A hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
A practical, down-to-earth look at Howmet’s 2026 earnings outlook. This guide breaks down drivers, risks, and actiona...
Hyperliquid and Cardano sit near the same market cap, but they serve very different purposes in crypto. This guide br...
A tech fund placed a sizable bet on a fresh AI chip IPO, wagering roughly $5.8 million. The stock climbed almost 200%...
As Daré gears up to discuss Q1 2026 results, investors will scrutinize cash runway, pipeline milestones, and strategi...
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
A china tech fund opens a biotech position, signaling a broader shift toward life sciences within tech-driven portfol...
A renewed focus on energy equities is lifting parts of the market today. This piece breaks down what’s driving the mo...